|
⚲
|
| Keyboard |
| Powell Matthew
✚
|
|
|---|---|
| CIK # | 0001529382 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001529382] | |
| 5 | [0001529382] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Powell Matthew | |
| Protea Biosciences Group Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Protea Biosciences Group Inc PRGB
Stock Option · derivative
|
2014-06-23 | Grant | 80,000 | $44,000.00 | 3,520,000,000 |
|
Protea Biosciences Group Inc NONE
Stock Option · derivative
|
2009-12-31 | Grant | 40,000 | $60,000.00 | 2,400,000,000 |
|
Protea Biosciences Group Inc NONE
Stock Option · derivative
|
2009-12-31 | Grant | 40,000 | $60,000.00 | 2,400,000,000 |
|
Protea Biosciences Group Inc NONE
Stock Option · derivative
|
2007-01-19 | Grant | 100,000 | $125,000.00 | 12,500,000,000 |
|
Protea Biosciences Group Inc NONE
Stock Option · derivative
|
2007-01-19 | Grant | 100,000 | $125,000.00 | 12,500,000,000 |
|
Protea Biosciences Group Inc NONE
Stock Option · derivative
|
2005-12-15 | Grant | 80,000 | $40,000.00 | 3,200,000,000 |
|
Protea Biosciences Group Inc NONE
Stock Option · derivative
|
2005-12-15 | Grant | 80,000 | $40,000.00 | 3,200,000,000 |